openPR Logo
Press release

Stem Cell Umbilical Cord Blood (UCB) Market to Reach a Valuation of $56.4 billion by 2020: Advanced Cell Technology, Athersys, California Stem Cell , Cytori Therapeutics and More

02-18-2019 10:35 AM CET | Health & Medicine

Press release from: Allied Market Research

Stem Cell Umbilical Cord Blood (UCB) Market

Stem Cell Umbilical Cord Blood (UCB) Market

Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost-effective method of treatment with fewer side effects. Global stem cell umbilical cord blood (UCB) market accounted for $6.5 billion in 2012, and is projected to reach $56.4 billion by 2020 registering a CAGR of 33.4% during the forecast period.

SWOT analysis and strategic developments included in the report for Key players: Advanced Cell Technology, Inc. (USA), Athersys, California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast, Opexa Therapeutics Geron Corporation, Neostem Inc.

Get Sample PDF Brochure of Stem Cell Umbilical Cord Blood (UCB) Market Study at: https://www.alliedmarketresearch.com/request-sample/114

Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies. This is set to propel the growth of stem cell umbilical cord blood (UCB) market in near future. Athersys, California Stem Cell Inc., and Cytori Therapeutics Inc. are engaged in the development of novel stem cell therapies from cord blood. Ethical issues regarding cord blood sample application is creating biasness among donor, which is majorly influencing the stem cell umbilical cord blood (UCB) market.

Intense competition among stem cell umbilical cord blood (UCB) market players has been witnessed with the companies trying to create brand awareness. This is therefore, compelling the market players to formulate market based strategies. Cord blood stem cell is the only type of stem cell that is stored in controlled condition due to its lower volume higher cell count feature. Storage service segment is expected grow at 33.4% CAGR from 2013-2020 in the global stem cell umbilical cord blood (UCB) market.

Key Benefits

• This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market
• Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision
• Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report
• Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/114

Key Market Segments:

By Storage
• Public cord blood banks
• Private cord blood banks
• Public Vs. Private UCB banks
By Diseases
• Cancer/ Oncology diseases
• Acute Leukemia
• Chronic Leukemia
• High Risk Solid Tumors
• Myelodysplastic Syndrome
• Blood diseases
• Aplastic Anemia
• Beta Thalassemia
• Sickle Cell disease
• Immune Disorders
• Leukocyte Adhesion Deficiency
• Hystiocytic Disorders
• Wiskott-Aldrich
• Metabolic Disorders
• Krabbe Disease
• Hurler Syndrome
• Sanfilippo Syndrome
• Other diseases
• Osteopetrosis
• Hemophagoyticlymphohistiocytosis

By Technology

• Stem Cell Transplant
• Autologous transplant
• Allogenic transplant
• Transplant Medicine
• Regenerative Medicine
• Others
• Cord Blood Banking
• Blood Transfusion
• Cell Based Genetics

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem Cell Umbilical Cord Blood (UCB) Market to Reach a Valuation of $56.4 billion by 2020: Advanced Cell Technology, Athersys, California Stem Cell , Cytori Therapeutics and More here

News-ID: 1595190 • Views: 375

More Releases from Allied Market Research

Turbocharger Market Share, Generating Revenue Of $24.23 Million By 2027 At a CAG …
op 10 leading companies in the global turbocharger market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and turbocharger products and services. The key players operating in the global turbocharger industry include BorgWarner Inc. Continental AG, Cummins Inc., EATON Corporation, Honeywell International Corporation, IHI Corporation, Mitsubishi Heavy Industries, Precision Turbo & Engine, Rotomaster International and Turbo Dynamics Ltd Latest news and industry developments
Commercial Satellite Imaging Market (Updated Research Report) Growth Analysis An …
The global commercial satellite imaging market was estimated at $2.24 billion in 2018 and is expected to reach $5.25 billion by 2026, growing at a CAGR of 11.2% from 2019-2026. The report offers a detailed analysis of the drivers & opportunities, top investment pockets, top winning strategies, market size & estimations, competitive scenario, and wavering market trends. Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1751 Increasing adoption of location-based service (LBS) and rising application of
Rolling Stock Market Price, Revenue, Gross Profit, Interview Record, Business Di …
Rolling Stock Market by Product Type (Locomotives, Rapid Transit (DMU, EMU, Light Rail, Metro) Wagons, Coaches), Locomotive Propulsion (Diesel and Electric), Application (Passenger & Freight), Components: Global Opportunity Analysis and Industry Forecast, 2019-2026.” According to the report, the global rolling stock industry garnered $58.60 billion in 2018, and is expected to reach $73.8 billion by 2026, growing at a CAGR of 2.9% from 2019 to 2026. Access Full Summary @ https://www.alliedmarketresearch.com/rolling-stock-market
Safety Relay Market Growth Projections and Performance Forecast Analysis for the …
Allied Market Research published a new report, titled, "Safety Relay Market by Type (Single-Function Safety Relays and Modular & Configurable Safety Relays), Contact (Normally Closed, Time Open (NCTO), Normally Closed, Time Closed (NCTC), Normally Open, Time Open (NOTO), Normally Open, Time Closed (NOTC)) and End User (Automotive, Energy & Power, Manufacturing, Pharmaceutical, Construction, Semiconductors, and Oil & Gas): Global Opportunity Analysis and Industry Forecast, 2020–2026." The research report offers an in-depth

All 5 Releases


More Releases for UCB

Global UCB Banking Market Will reach $19,335.6 million in 2020
According to a new market report published by Persistence Market Research “Global Market Study on UCB Banking – Asia-Pacific to Witness Highest Growth by 2020” the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020. The UCB banking market is witnessing a significant
Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
UCB Banking Market to Reflect Steady Growth Rate by 2020
According to a new market report published by Persistence Market Research “Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020” the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020. The UCB banking market is witnessing a
Global UCB Banking Market Will reach $19,335.6 million in 2020
According to a new market report published by Persistence Market Research “Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020” the global UCB banking market is estimated at USD 13,515.8 million in 2014 and is expected to grow at a CAGR of 6.1% from 2014 to 2020, to reach an estimated value of USD 19,335.6 million in 2020. Request Report for TOC @ https://www.persistencemarketresearch.com/market-research/umbilical-cord-blood-banking-market/toc The UCB
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021. Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing
Cetirizine Hydrochloride Market 2017- UCB Pharma, Pfizer, J & J, Mylan
Cetirizine Hydrochloride Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist. Second-generation antihistamines like cetirizine